https://bit.ly/3rOYIL2.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845010PMC
http://dx.doi.org/10.1183/23120541.00014-2022DOI Listing

Publication Analysis

Top Keywords

inhaled corticosteroids
4
corticosteroids covid-19
4
covid-19 outcomes
4
outcomes asthma
4
asthma israeli
4
israeli experience
4
experience https//bitly/3royil2
4
inhaled
1
covid-19
1
outcomes
1

Similar Publications

Background: Genetic factors play a role in asthma severity. However, low- and middle-income countries have minimal contribution to genomic asthma research. The current study investigates the influence of an important genetic asthma region (6p21) on severe asthma in a cohort of asthmatics in Pakistan.

View Article and Find Full Text PDF

Background: Global Initiative for Asthma (GINA) recently recommends clinicians to reduce inhaled corticosteroid doses in patients with severe asthma who respond positively to monoclonal antibodies (MAbs).

Objective: As we operated this reduction even before the document, we analysed our cohort of subjects on treatment with a MAbs for at least 24 months.

Methods: Data stored in our electronic archive and at the 6-month follow-up (FU) were registered and patients' adherence to asthma therapy was derived by electronic pharmacy claim database.

View Article and Find Full Text PDF

Introduction: Physical inactivity due to shortness of breath is common among patients with uncontrolled asthma. We evaluated the body mass composition and exercise capacity of patients with poorly controlled asthma, despite maximal inhalation therapy.

Methods:  We recruited 56 patients from the Asthma Clinic of the University Hospital of Liège between September 2020 and December 2023, and 14 healthy subjects.

View Article and Find Full Text PDF

[Annual research progress in chronic obstructive pulmonary disease 2024].

Zhonghua Jie He He Hu Xi Za Zhi

January 2025

National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Hetao Institute of Guangzhou National Laboratory, Shenzhen518000, China.

Article Synopsis
  • COPD is a growing global health issue, with recent advancements in early detection and personalized treatment, highlighting the importance of monitoring early-stage disease for better prognosis.
  • Research has identified critical areas in the lungs as initial sites of damage, and specific biomarkers may help track different disease progression patterns.
  • New treatment strategies, including triple inhalation therapy and innovative medications, show promise in managing symptoms and improving patient outcomes in COPD, with ongoing research aimed at understanding disease variability.
View Article and Find Full Text PDF

Treatment patterns for chronic obstructive pulmonary disease under the tiered medical system.

Sci Rep

January 2025

Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.

China has implemented the "tiered medical services" policy since 2015, while there is a paucity of data evaluating the the current status of chronic obstructive pulmonary disease (COPD) management under the system. Characteristics and treatments from 11,905 COPD patients in 88 hospitals across different tiers in China were included and analyzed. We assessed the statistical significance of differences by one way analysis of variance (ANOVA) for continuous variables and with the chi-squared test for categorical variables.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!